ANDREA RICHARDS: Open Payments
NPI 1356833073 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 23 payments from 8 companies in 2025. Trend: 2023 $411 · 2024 $157 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $156 |
| Amgen Inc. | 4 | $80 |
| Alexion Pharmaceuticals, Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| UCB, Inc. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $19 |
Products named: SKYRIZI, OTEZLA, RINVOQ, STRENSIQ, ORENCIA, COSENTYX, BENLYSTA, Bimzelx.
Industry payments across NC — which companies pay providers there.
